ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Halozyme Therapeutics, Inc. 

11388 Sorrento Valley Road

San Diego  California  92121  U.S.A.
Phone: 858-794-8889 Fax: 858-259-2539


SEARCH JOBS
Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, which increase the dispersion and absorption of biologics, drugs and fluids. Halozyme's pipeline addresses therapeutic areas, including diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Pfizer, Baxter, and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

 Key Statistics


Email: hr@halozyme.com
Ownership: Public

Web Site: Halozyme Therapeutics, Inc.
Employees: 152
Symbol: HALO
 









 Company News
FDA Orders Halozyme Therapeutics, Inc. (HALO) To Halt Pancreatic Cancer Study 4/10/2014 6:15:25 AM    More...
Halozyme Therapeutics, Inc. (HALO) Announces Preclinical Data Presentations At The American Association for Cancer Research Annual Meeting 4/8/2014 8:30:49 AM    More...
Halozyme Therapeutics, Inc. (HALO) Tanks As Enrollment In Phase 2 Pancreatic Cancer Study Is Halted; Stock Down -27.26% At 5:20PM ET (April 4, 2014) 4/4/2014 6:58:26 AM    More...
Halozyme Therapeutics, Inc. (HALO) Announces Appointment Of Oncology Product Team Leader And Other Executive Transitions 4/2/2014 6:42:59 AM    More...
Halozyme Therapeutics, Inc. (HALO) To Present At The Barclays 2014 Global Healthcare Conference 3/5/2014 7:17:33 AM    More...
Halozyme Therapeutics, Inc. (HALO) Reports Fourth Quarter And Year End 2013 Financial Results 2/28/2014 6:26:31 AM    More...
Halozyme Therapeutics, Inc. (HALO) To Present At The Cowen and Company 34th Annual Healthcare Conference 2/26/2014 6:17:47 AM    More...
Halozyme Therapeutics, Inc. (HALO) To Host Fourth Quarter And 2013 Year-End Financial Results Conference Call 2/21/2014 6:25:03 AM    More...
Halozyme Therapeutics, Inc. (HALO) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/10/2014 2:38:32 PM    More...
Halozyme Therapeutics, Inc. (HALO) Prices Public Offering Of Common Stock 2/5/2014 5:25:01 AM    More...
12345678910...